Innate Pharma (IPHA) EPS (Basic) (2018 - 2025)
Innate Pharma posted quarterly EPS (Basic) of $0.23 for Q4 2025, up 133.3% year-on-year from $0.1 in Q4 2024, and up 100.0% on a QoQ basis from -$85376.0 in Q2 2025.
Innate Pharma (IPHA) has 8 years of EPS (Basic) data on file, last reported at $0.23 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Basic) rose 133.3% year-over-year to $0.23; the trailing twelve-month figure through Dec 2025 stood at -$165260.3 (down 220.99% YoY), and the FY2025 full-year result was -$0.64, up 1.78% from the prior year.
- EPS (Basic) for Q4 2025 stood at $0.23, up from -$85376.0 in the prior quarter.
- Across five years, EPS (Basic) topped out at $28400.0 in Q2 2023 and bottomed at -$85376.0 in Q2 2025.
- The 5-year median for EPS (Basic) is -$0.69 (2024), against an average of -$11603.3.
- The widest annual swing landed in 2023, when EPS (Basic) soared 3102745112.05%; it then tumbled 381.28% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$1.44 in 2021, then jumped by 53.21% to -$0.68 in 2022, then retreated by 9.49% to -$0.74 in 2023, then gained by 5.91% to -$0.7 in 2024, then soared by 133.3% to $0.23 in 2025.
- The last three EPS (Basic) figures came in at $0.23 (Q4 2025), -$85376.0 (Q2 2025), and -$0.7 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 4.06 |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 6.99 |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.55 |
| 10 | Innate Pharma | 199.64 Mn | 199.64 Mn | - | 0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.63 |
| Jun 30, 2025 | -85,376.00 |
| Dec 31, 2024 | -13.91 |
| Jun 30, 2024 | -79,883.87 |
| Dec 31, 2023 | -14.71 |
| Jun 30, 2023 | 28,400.00 |
| Dec 31, 2022 | -0.68 |
| Jun 30, 2022 | 0.00 |
| Dec 31, 2021 | -1.44 |
| Jun 30, 2021 | 20,830.00 |
| Dec 31, 2020 | -15,152.19 |
| Jun 30, 2020 | 0.00 |
| Dec 31, 2019 | -3.02 |
| Dec 31, 2018 | -2.62 |